ClinicalTrials.Veeva

Menu

Analgesia After Total Knee Replacement Surgery

S

St. Antonius Hospital

Status

Completed

Conditions

Total Knee Arthroplasty

Treatments

Drug: naropin
Drug: marcaine
Drug: neurontin
Drug: sufentanil

Study type

Interventional

Funder types

Other

Identifiers

NCT01489631
TKP-37796

Details and patient eligibility

About

Postoperative pain after total knee replacement surgery is difficult to treat. Mobilisation and hospital discharge might be delayed. Recent research shows that intra-articular infiltration with local anesthetics and perioperative prescription of gabapentin can improve outcome.

Objective of the study: Comparison of mobilisation speed and postoperative NRS-scores of patients after total knee replacement surgery which is treated with epidural analgesia or peroperative infiltration of the knee. Appraisal of the value of gabapentin for reduction of postoperative opiate consumption.

Full description

Study design:

Prospective randomised study

Study population:

Patients aged eighteen years or older, in whom knee replacement surgery is indicated. They will have spinal anaesthesia and epidural analgesia if indicated by randomisation. They must not have contraindications for epidural analgesia or the used medication in this study.

Intervention:

The first group will be treated with epidural analgesia. Before surgery the epidural catheter will be placed according to local guidelines. After the operation epidural infiltration with bupivacaine and sufentanil will be commenced. The second group will receive local infiltration with ropivacaine of the knee during surgery. Half of these patients will additionally be treated with gabapentin.

Primary study parameters/outcome of the study:

NRS-score (11-scale Numeric Rating Scale in which 0 means no pain, and 10 means most pain imaginable) in rest.

Secondary study parameters/outcome of the study:

Speed of mobilisation, postoperative opiate consumption. NRS scores during flexion exercise of the knee and during walking exercise.

Enrollment

81 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years or older and legally responsible
  • Waiting for total knee replacement surgery
  • Informed consent

Exclusion criteria

  • Contraindications for epidural analgesia
  • Aortic Valve stenosis
  • Severely compromised cardiac function
  • infection near epidural punction site
  • Redo knee surgery
  • Previous arthrotomies
  • Allergy/Hypersensitivity for study mediation or all other used medication
  • Participation in other studies

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

81 participants in 3 patient groups

epidural analgesia
Active Comparator group
Description:
The first group will be treated with epidural analgesia. Before surgery the epidural catheter will be placed according to local guidelines. After the operation epidural infiltration with bupivacaine and sufentanil will be commenced.
Treatment:
Drug: sufentanil
Drug: marcaine
local infiltration
Active Comparator group
Description:
The second group will receive local infiltration with ropivacaine of the knee during surgery.
Treatment:
Drug: naropin
local infiltration and gabapentin
Active Comparator group
Description:
The third group will receive local infiltration with ropivacaine of the knee during surgery and will additionally be treated with gabapentin.
Treatment:
Drug: neurontin
Drug: naropin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems